1-11 of 11
Ajay Kakkar
Close
Sort by
Journal Articles

Post-Hoc Analysis of RE-MEDY™ Demonstrates Significant Real-World Net Clinical Benefit for Dabigatran Versus Warfarin in Prevention of Secondary Venous Thromboembolism

Sam Schulman, MD PhD, Henry Eriksson, MD PhD, Ajay Kakkar, MB, BS, PhD, Clive Kearon, MB, PhD, Sebastian M Schellong, MD, Patrick Mismetti, MD PhD, Martin Feuring, MD, Stefan Hantel, PhD, Joerg Kreuzer, MD, Samuel Z. Goldhaber, MD
Journal: Blood
Blood (2014) 124 (21): 4270.
https://doi.org/10.1182/blood.V124.21.4270.4270
Published: 2014
Journal Articles

Influence of Age and Renal Function on Efficacy and Safety of Dabigatran Versus Warfarin for the Treatment of Acute Venous Thromboembolism: A Pooled Analysis of RE-COVER™ and RE-COVER™ II

Sam Schulman, MD PhD, Henry Eriksson, MD PhD, Ajay Kakkar, MB, BS, PhD, Clive Kearon, MB, PhD, Sebastian M Schellong, MD, Patrick Mismetti, MD, Martin Feuring, MD, Stefan Hantel, PhD, Joerg Kreuzer, MD, Samuel Z. Goldhaber, MD
Journal: Blood
Blood (2014) 124 (21): 594.
https://doi.org/10.1182/blood.V124.21.594.594
Published: 2014
Journal Articles

Influence of Thrombophilia on the Efficacy of Dabigatran Versus Warfarin for the Extended Treatment of Acute Venous Thromboembolism in RE-MEDY™

Sam Schulman, MD PhD, Henry Eriksson, MD PhD, Samuel Z. Goldhaber, MD, Ajay Kakkar, MB, BS, PhD, Clive Kearon, MB, PhD, Sebastian M Schellong, MD, Martin Feuring, MD, Jeffrey Friedman, MD, Joerg Kreuzer, MD
Journal: Blood
Blood (2014) 124 (21): 1544.
https://doi.org/10.1182/blood.V124.21.1544.1544
Published: 2014
Journal Articles

Influence Of Age On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis Of RE-Cover and RE-Cover II

Sam Schulman, MD, PhD, Henry Eriksson, MD, PhD, Samuel Z Goldhaber, MD, Ajay Kakkar, MB, BS, PhD, Clive Kearon, MB, PhD, Sebastian M Schellong, MD, Joerg Kreuzer, MD, Nuala Peter, BSc (Hons), Jeffrey Friedman, MD
Journal: Blood
Blood (2013) 122 (21): 2375.
https://doi.org/10.1182/blood.V122.21.2375.2375
Published: 2013
Journal Articles

Influence Of Concomitant NSAID Or ASA On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II

Sam Schulman, MD, PhD, Henry Eriksson, MD, PhD, Samuel Z Goldhaber, MD, Ajay Kakkar, MB, BS, PhD, Clive Kearon, MB, PhD, Sebastian M Schellong, MD, Martin Feuring, MD, Nuala Peter, BSc (Hons), Jeffrey Friedman, MD
Journal: Blood
Blood (2013) 122 (21): 1136.
https://doi.org/10.1182/blood.V122.21.1136.1136
Published: 2013
Journal Articles

Influence Of Active Cancer On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II

Sam Schulman, MD, PhD, Henry Eriksson, MD, PhD, Samuel Z Goldhaber, MD, Ajay Kakkar, MB, BS, PhD, Clive Kearon, MB, PhD, Sebastian M Schellong, MD, Martin Feuring, MD, Nuala Peter, BSc (Hons), Jeffrey Friedman, MD
Journal: Blood
Blood (2013) 122 (21): 582.
https://doi.org/10.1182/blood.V122.21.582.582
Published: 2013
Journal Articles

Influence Of Renal Function On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II

Sam Schulman, MD, PhD, Henry Eriksson, MD, PhD, Samuel Z Goldhaber, MD, Ajay Kakkar, MB, BS, PhD, Clive Kearon, MB, PhD, Sebastian M Schellong, MD, Martin Feuring, MD, Nuala Peter, BSc (Hons), Jeffrey Friedman, MD
Journal: Blood
Blood (2013) 122 (21): 212.
https://doi.org/10.1182/blood.V122.21.212.212
Published: 2013
Journal Articles

International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients

Farge Dominique, Debourdeau Philippe, Beckers Marielle, Caroline Baglin, Rupert Bauersachs, Benjamin Brenner, MD, Dialina Brilhante, MD, Anna Falanga, MD, Grigoris T Gerotziafas, Nissim Haim, Ajay Kakkar, MD, Alok A. Khorana, MD, Ramon Lecumberri, Mario Mandala, Michel Marthy, Manuel Monreal, MD, PhD, Shaker S Mousa, Simon Noble, Ingrid Pabinger, MD, Paolo Prandoni, Martin Prins, MD, PhD, Mohammed H. Qari, Michael B. Streiff, MD, Konstantin Syrigos, Henri Bounameaux, MD, Harry Roger Buller, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1161.
https://doi.org/10.1182/blood.V120.21.1161.1161
Published: 2012
Journal Articles

Benefit of Extended Maintenance Therapy for Venous Thromboembolism with Dabigatran Etexilate Is Maintained Over 1 Year of Post-Treatment Follow-up

Sam Schulman, MD, PhD, David Baanstra, MD, Henry Eriksson, MD, Samuel Z. Goldhaber, MD, Ajay Kakkar, MD, Clive Kearon, MD, PhD, Sebastian Schellong, MD, Jeffrey Friedman, MD
Journal: Blood
Blood (2012) 120 (21): 21.
https://doi.org/10.1182/blood.V120.21.21.21
Published: 2012
Journal Articles

International Clinical Practice Guidelines for the Treatment and Prophylaxis of Thrombosis Associated with Central Venous Catheters in Patients with Cancer

Debourdeau Philippe, Farge Dominique, Beckers Marielle, Caroline Baglin, Rupert Bauersachs, Benjamin Brenner, MD, Dialina Brilhante, MD, Anna Falanga, MD, Grigoris T Gerotziafas, Nissim Haim, Ajay Kakkar, MD, Alok A. Khorana, MD, Ramon Lecumberri, Mario Mandala, Michel Marty, Manuel Monreal, MD, PhD, Shaker S Mousa, Simon Noble, Ingrid Pabinger, MD, Paolo Prandoni, Martin Prins, MD, PhD, Mohammed H. Qari, Michael B. Streiff, MD, Konstantin Syrigos, Harry Roger Buller, MD, PhD, Henri Bounameaux, MD
Journal: Blood
Blood (2012) 120 (21): 4357.
https://doi.org/10.1182/blood.V120.21.4357.4357
Published: 2012
Journal Articles

Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO

Daniel George, Giancarlo Agnelli, William Fisher, Ajay Kakkar, Michael R Lassen, Patrick Mismetti, Patrick Mouret, Francesca Lawson, Alexander G.G. Turpie
Journal: Blood
Blood (2011) 118 (21): 206.
https://doi.org/10.1182/blood.V118.21.206.206
Published: 2011